146 related articles for article (PubMed ID: 2883148)
1. Beta-endorphin. Biological activity of analogs containing dermorphin and dynorphin sequences: ileum and vas deferens assays.
Ho CL; Li CH
Int J Pept Protein Res; 1987 Jan; 29(1):134-9. PubMed ID: 2883148
[TBL] [Abstract][Full Text] [Related]
2. Beta-endorphin. Biological activity of synthetic analogs with analgesia inhibiting property in rat vas deferens and guinea pig ileum assays.
Ho CL; Li CH
Int J Pept Protein Res; 1985 Mar; 25(3):305-7. PubMed ID: 3158621
[TBL] [Abstract][Full Text] [Related]
3. Analgesic, receptor binding, and peripheral opioid activities of synthetic dermorphin-dynorphin hybrid peptides.
Ho CL; Ko JL; Hwang LL; Wang KT
Int J Pept Protein Res; 1990 Feb; 35(2):99-104. PubMed ID: 1969854
[TBL] [Abstract][Full Text] [Related]
4. Beta-endorphin: peripheral opioid activity of homologues from six species.
Ho CL; Ko JL; Li CH
Int J Pept Protein Res; 1987 Apr; 29(4):521-4. PubMed ID: 2954920
[TBL] [Abstract][Full Text] [Related]
5. The choice of opioid receptor subtype in isolated preparations by dynorphins.
Oka T; Aoki K; Kajiwara M
Life Sci; 1983; 33 Suppl 1():311-4. PubMed ID: 6141492
[TBL] [Abstract][Full Text] [Related]
6. [2',6'-Dimethyltyrosine]dynorphin A(1-11)-NH2 analogues lacking an N-terminal amino group: potent and selective kappa opioid antagonists.
Lu Y; Nguyen TM; Weltrowska G; Berezowska I; Lemieux C; Chung NN; Schiller PW
J Med Chem; 2001 Sep; 44(19):3048-53. PubMed ID: 11543672
[TBL] [Abstract][Full Text] [Related]
7. Studies on the structural prerequisites for the activation of the beta-endorphin receptor on the rat vas deferens.
Huidobro-Toro JP; Caturay EM; Ling N; Lee NM; Loh HH; Way EL
J Pharmacol Exp Ther; 1982 Jul; 222(1):262-9. PubMed ID: 6123591
[TBL] [Abstract][Full Text] [Related]
8. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens.
Sagan S; Corbett AD; Amiche M; Delfour A; Nicolas P; Kosterlitz HW
Br J Pharmacol; 1991 Oct; 104(2):428-32. PubMed ID: 1665735
[TBL] [Abstract][Full Text] [Related]
9. The choice of opiate receptor subtype by neo-endorphins.
Oka T; Negishi K; Kajiwara M; Watanabe Y; Ishizuka Y; Matsumiya T
Eur J Pharmacol; 1982 Apr; 79(3-4):301-5. PubMed ID: 6284522
[TBL] [Abstract][Full Text] [Related]
10. Irreversible blockade of the kappa-receptor by a newly synthesized dynorphin derivative containing a 3-nitro-2-pyridinesulfenyl group.
Koike K; Takayanagi I; Hirakura Y; Matsueda R
Arch Int Pharmacodyn Ther; 1991; 313():33-46. PubMed ID: 1687773
[TBL] [Abstract][Full Text] [Related]
11. The relative potency of enkephalins and beta-endorphin in guinea-pig ileum, mouse vas deferens and rat vas deferens after the administration of peptidase inhibitors.
Kuno Y; Aoki K; Kajiwara M; Ishii K; Oka T
Jpn J Pharmacol; 1986 Jul; 41(3):273-81. PubMed ID: 3761746
[TBL] [Abstract][Full Text] [Related]
12. Binding characteristics of dermorphin, and [dermorphin1-7]-beta c-endorphin in rat brain membranes.
Westphal M; Hammonds RG; Li CH
Peptides; 1985; 6(1):149-52. PubMed ID: 2986079
[TBL] [Abstract][Full Text] [Related]
13. Peptide models of dynorphin A(1-17) incorporating minimally homologous substitutes for the potential amphiphilic beta strand in residues 7-15.
Taylor JW
Biochemistry; 1990 Jun; 29(22):5364-73. PubMed ID: 1974458
[TBL] [Abstract][Full Text] [Related]
14. Biological and physical properties of a beta-endorphin analog containing only D-amino acids in the amphiphilic helical segment 13-31.
Blanc JP; Kaiser ET
J Biol Chem; 1984 Aug; 259(15):9549-56. PubMed ID: 6086639
[TBL] [Abstract][Full Text] [Related]
15. Guinea-pig ileum (GPI) and mouse vas deferens (MVD) preparations in the discovery, discrimination and parallel bioassay of opioid peptides.
Erspamer GF; Severini C
Pharmacol Res; 1992 Sep; 26(2):109-21. PubMed ID: 1329062
[TBL] [Abstract][Full Text] [Related]
16. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors.
Oka T; Negishi K; Suda M; Sawa A; Fujino M; Wakimasu M
Eur J Pharmacol; 1982 Jan; 77(2-3):137-41. PubMed ID: 6277659
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and properties of beta h-endorphin analogs containing the dynorphin-(1-13) sequence.
Li CH; Yamashiro D; Ferrara P; Tseng LF; Way EL
Int J Pept Protein Res; 1983 Apr; 21(4):331-5. PubMed ID: 6305857
[TBL] [Abstract][Full Text] [Related]
18. Dermorphin interaction with peripheral opioid receptors.
Giagnoni G; Parolaro D; Casiraghi L; Crema G; Sala M; Andreis C; Gori E
Neuropeptides; 1984 Dec; 5(1-3):157-60. PubMed ID: 6099487
[TBL] [Abstract][Full Text] [Related]
19. Examination of the requirement for an amphiphilic helical structure in beta-endorphin through the design, synthesis, and study of model peptides.
Blanc JP; Taylor JW; Miller RJ; Kaiser ET
J Biol Chem; 1983 Jul; 258(13):8277-84. PubMed ID: 6305980
[TBL] [Abstract][Full Text] [Related]
20. Beta-endorphin. Receptor binding and peripheral opioid activities of [Gln8]-, [Trp27]-, and [Tyr31]-analogs.
Ho CL; Ko JL; Li CH
Int J Pept Protein Res; 1988 Jul; 32(1):74-8. PubMed ID: 2851563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
